| Element List | Current Year | Previous Year | %Change | ||
|---|---|---|---|---|---|
| Sales/Revenue | 45,456,900 | 33,918,786 | 34.02 | ||
| Gross Profit (Loss) | 13,318,443 | 11,113,030 | 19.84 | ||
| Operational Profit (Loss) | 8,081,905 | 6,971,296 | 15.93 | ||
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 7,304,596 | 6,300,855 | 15.93 | ||
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 7,230,880 | 6,008,181 | 20.35 | ||
| Total Shareholders Equity (after Deducting Minority Equity) | 46,074,946 | 22,311,066 | 106.51 | ||
| Profit (Loss) per Share | 0.4 | 0.55 | |||
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | - | - | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current year compared to the last year | The company's revenues increased by 34.02% to reach 45,456,900 riyals compared to 33,918,786 riyals in the previous year, an increase of 11,538,114 riyals. This growth is attributable to the expansion of business operations, as well as an increase in operational capacity, doctors, and the number of patients served. |
| The reason of the increase (decrease) in the net profit during the current year compared to the last year is | The company recorded a 19.85% increase in gross profit to reach 13,318,443 riyals compared to 11,113,030 riyals in the previous year, an increase of 2,205,413 riyals. The company’s net profit after zakat and tax increased by 15.93% to reach 7,304,596 riyals compared to 6,300,855 riyals in the previous year, an increase of 1,003,741 riyals. This growth is primarily attributed to the increase in revenues, which positively impacted financial performance. |
| Statement of the type of external auditor's report | Unmodified opinion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | Nothing |
| Reclassification of Comparison Items | In accordance with the financial statements, certain comparative figures have been reclassified, where necessary, to ensure consistency and alignment with the presentation adopted in the current financial year. |
| Additional Information | Basic and diluted earnings per share (EPS) have been calculated by dividing the net profit for the year by the weighted average number of ordinary shares outstanding during the year,The Company does not have any potentially dilutive shares or instruments; therefore, the diluted earnings per share is the same as the basic earnings per share. The weighted average number of shares outstanding for the year ended 2025 was 18,038,356 shares, compared to 11,550,685 shares for the year ended 2024. |
